Regular physical activity supports overall metabolic health
The TRIUMPH cardiovascular outcomes trial is ongoing with results expected in 2027-2028
Triple-Action Structure With Added Glucagon Retatrutide is a triple-action therapy that, like Lillys Mounjaro and Zepbound drugs, targets glucagon-like peptide-1, or GLP-1, and glucose-dependent insulinotropic polypeptide, or GIP, while also acting on the glucagon receptor
In the Goto-Kakizaki (GK) rat, a spontaneous model of T2DM [51], intravitreal E4 prevented cell loss in the GCL and outer nuclear layer (ONL) without affecting systemic glucose levels, suggesting a local retinal mechanism
Myers cocktails are a specific blend of B complex, B5, B6, B12, vitamin C and magnesium